{"transactions":[{"id":756785,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":42746,"kind":"person","name":"Grauer Andreas","position":1,"cik":"0001770511","reported_name":"Grauer Andreas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-02T01:15:27.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following May 28, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":7.27,"expiration_date":"2036-05-27","underlying":"Series A Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-26-069123","document":"tm2616578-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926069123/tm2616578-3_4seq1.xml","form_type":"4"}},{"id":778741,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":42746,"kind":"person","name":"Grauer Andreas","position":1,"cik":"0001770511","reported_name":"Grauer Andreas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T21:15:39.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":264759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on April 20, 2027, with the remaining 75% vesting over thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":264759,"derivative":{"exercise_price":6.44,"expiration_date":"2036-04-19","underlying":"Series A Common Stock","underlying_shares":264759},"source":{"system":"sec-edgar","filing":"0001104659-26-061327","document":"tm2614553-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926061327/tm2614553-2_4seq1.xml","form_type":"4"}},{"id":2875107,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42746,"kind":"person","name":"Grauer Andreas","position":1,"cik":"0001770511","reported_name":"Grauer Andreas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T22:15:30.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 5, 2021, so that the total number of shares subject to this option becomes fully vested and exercisable on February 5, 2025."}],"balance_after":200000,"derivative":{"exercise_price":29.41,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-21-005183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321005183/doc4.xml","form_type":"4"}},{"id":3280257,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42746,"kind":"person","name":"Grauer Andreas","position":1,"cik":"0001770511","reported_name":"Grauer Andreas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-11T22:09:55.000Z","date":"2020-02-07","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2024."}],"balance_after":150000,"derivative":{"exercise_price":13.56,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-20-004040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924320004040/doc4.xml","form_type":"4"}},{"id":3569672,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42746,"kind":"person","name":"Grauer Andreas","position":1,"cik":"0001770511","reported_name":"Grauer Andreas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T17:36:52.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 25% of the total number of shares on the one-year anniversary of March 18, 2019 and 1/36th of the remaining number of shares on each monthly anniversary thereafter, so that the total number of shares subject to this option becomes fully vested and exercisable on March 18, 2023."}],"balance_after":425000,"derivative":{"exercise_price":11.29,"expiration_date":"2029-03-31","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0000899243-19-009521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319009521/doc4.xml","form_type":"4"}}]}